PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-12
DOI
10.1038/s41379-019-0261-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
- (2018) Christopher K. Bichakjian et al. Journal of the National Comprehensive Cancer Network
- Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
- (2018) Sandra P. D’Angelo et al. JAMA Oncology
- Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
- (2018) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- PD-1 ( PDCD1 ) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase ( IDH ) Mutations
- (2018) Lea Kristin Röver et al. EBioMedicine
- PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma
- (2017) Christina Mitteldorf et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas
- (2017) María del Carmen González-Vela et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
- (2017) Diane Goltz et al. Oncotarget
- CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel
- (2017) Luca Morandi et al. Clinical Epigenetics
- Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System
- (2016) Kelly L. Harms et al. ANNALS OF SURGICAL ONCOLOGY
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
- (2016) Howard L Kaufman et al. LANCET ONCOLOGY
- PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
- (2016) Paul T. Nghiem et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update
- (2016) Enis Afgan et al. NUCLEIC ACIDS RESEARCH
- Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
- (2016) Diane Goltz et al. OncoImmunology
- SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation
- (2016) Wei Shen et al. PLoS One
- The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma
- (2015) Paul William Harms et al. CANCER RESEARCH
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
- (2015) Sonja Kleffel et al. CELL
- DNA methylation analysis by bisulfite next-generation sequencing for early detection of oral squamous cell carcinoma and high-grade squamous intraepithelial lesion from oral brushing
- (2015) Luca Morandi et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma
- (2014) Jayasri G. Iyer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pathologic nodal evaluation is increasingly commonly performed for patients with Merkel cell carcinoma
- (2013) Kelly G. Paulson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
- (2013) E. J. Lipson et al. Cancer Immunology Research
- Recurrence and Survival in Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma: Analysis of 153 Patients from a Single Institution
- (2011) Ryan C. Fields et al. ANNALS OF SURGICAL ONCOLOGY
- Expression of p63 is the sole independent marker of aggressiveness in localised (stage I–II) Merkel cell carcinomas
- (2011) Sofia Asioli et al. MODERN PATHOLOGY
- Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
- (2010) T. Schatton et al. CANCER RESEARCH
- Importance of sentinel lymph node biopsy in Merkel cell carcinoma
- (2010) Riei KAMO et al. JOURNAL OF DERMATOLOGY
- Merkel Cell Carcinoma: Recent Progress and Current Priorities on Etiology, Pathogenesis, and Clinical Management
- (2009) JOURNAL OF CLINICAL ONCOLOGY
- Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
- (2008) H. Feng et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started